Vaccine
-
Solutions
- Live Attenuated & Killed Vaccine Design
- Subunit Vaccine Design
- Hapten Conjugate Vaccine Design
- Totally Synthetic Vaccine Design
- DNA & RNA Vaccine Design
- Viral Vector Vaccine Design
- Bacterial Vector Vaccine Design
- Virus-Like Particle based Vaccine Design
- Cell based Vaccine Design
- Plant based Vaccine Design
- Bacterial Vaccine Design
- Viral Vaccine Design
- Fungal Vaccine Design
- Parasitic Vaccine Design
- HBV Vaccine Design
- HPV Vaccine Design
- Diabetes Mellitus Vaccine Design
- Autoimmune Disease related Vaccine Design
- Neurodegenerative Disease related Vaccine Design
-
Allergic Disease related Vaccine Design
- Target-Ag® Platform
- Peanut Allergy Vaccine Design
- Plant Pollens Allergy Vaccine Design
- Cow’s Milk Allergy Vaccine Design
- Egg Allergy Vaccine Design
- Seafood Allergy Vaccine Design
- Fruit Allergy Vaccine Design
- Bee Venom Allergy Vaccine Design
- Latex Allergy Vaccine Design
- Furry Animals Allergy Vaccine Design
- Tree Nut Allergy Vaccine Design
- House Dust Mite Induced Allergic Asthma Vaccine Design
- Exosome-based Vaccine Design
- Universal Vaccine Design
-
Services
- Vaccine Design
-
Vaccine Formulation Development
- Formulation Optimization
- Delivery System Optimization
- Adjuvant Optimization
- Adjuvant Selection
- PRR Ligand Scanning
- Custom Adjuvant Synthesis
- Mineral Salt Adjuvant related Optimization
- Oil Adjuvant related Optimization
- Saponin related Optimization
- Lipopolysaccharide related Optimization
- CpG related Optimization
- Bacteria-derived Adjuvant Optimization
- Adjuvant Emulsion Optimization
- Innate Immune Stimulator Design
- RNA-based Adjuvant Optimization
- Vaccine Analytical Development & Qualification
-
Vaccine GMP Manufacturing
- Expression System Evaluation
- Bacterial Expression System for Vaccine Production
- Yeast Expression System for Vaccine Production
- Baculovirus-Insect Expression System for Vaccine Production
- Mammalian Cell Expression System for Vaccine Production
- Plant Expression System for Vaccine Production
- Cell-free Expression System for Vaccine Production
- Small-Scale Process Development
- Scale-Up Development
- Vaccine GMP Production
- Serum-Free Suspension Culture
- GMP-grade Antigen Production
- Expression System Evaluation
-
Cancer Vaccines
-
Cancer Vaccine Development
- Cutaneous Cancer related Vaccine Development
- Genitourinary Cancer related Vaccine Development
- Gynecologic Cancer related Vaccine Development
- Gastrointestinal Cancer related Vaccine Development
- Breast Cancer related Vaccine Development
- Lung Cancer related Vaccine Development
- Head and Neck Cancer related Vaccine Development
- Blood Cancer related Vaccine Development
- Brain Tumor related Vaccine Development
- Sarcomas related Vaccine Development
- Pediatric Cancer related Vaccine Development
- Neuroendocrine Tumor related Vaccine Development
- Thyroid Cancer related Vaccine Development
-
Cancer Vaccine Type
- Neoantigen Cancer Vaccine Development
- Tumor Cell Vaccine Development
- Dendritic Cell Vaccine Development
- Antigen Vaccine Development
- Anti-Idiotype Vaccine Development
- DNA based Cancer Vaccine Development
- mRNA based Cancer Vaccine Development
- Vector based Vaccine Development
- Fully Synthetic Carbohydrate based Cancer Vaccine Development
- BCG Vaccine Development
- Ty21 based Vaccine Development
- Exosome based Therapeutic Cancer Vaccine Development
- Ag-Fc Fusion Protein based Vaccine Development
- Biomaterial-based Implantable Cancer Vaccine Development
- Cytomegalovirus based Cancer Immunotherapy Development
- Immunological Checkpoint Therapy Development
- Immunoplacental Therapy Development
- Cancer Vaccine Technology
-
Cancer Vaccine Development
- Products
- Supports
- Company
